Highlights of the Day

Asian Markets

Asian shares rose to near two-year highs as growing optimism over tech industry earnings and easing concerns over North Korea offset softer-than-expected factory readings in China and the United States.

U.S. Markets

The tech-heavy Nasdaq closed at a record, with shares of Apple hitting a new high, while the Dow industrials slipped lower as investors digested a raft of economic reports and looked ahead to the start of the Federal Reserve’s policy meeting tomorrow.

Today's News

Today’s News

Donald Trump said he is considering breaking up big Wall Street banks, by splitting their consumer business from their investment operations. He is reported to have told Bloomberg News “I’m looking at that right now,”. White House spokesman Sean Spicer said there were no further details and no announcement was planned. Shares in banks initially fell after President Trump’s comments before recovering ground. US banks were permitted to own both High Street banks and investment banking operations in 1999, when the Glass-Steagall Act was repealed.

 

BP benefitted from higher oil prices and production helped improve its bottom line. BP reported first-quarter underlying replacement cost profit, the company’s definition of net income, of $1.51bn, exceeding analysts’ average forecast of $1.26bn. Oil prices, a major driver for BP’s earnings, averaged around 35% above prior-year levels, helping to boost revenue from its core oil and gas production division.

 

Aberdeen Asset Management and Standard Life have agreed to pay roughly £35.0mn to a cluster of executives to prevent them quitting during the proposed £11bnon merger between the pair.  The retention bonuses are understood to be payable to fund managers who remain with the combined group for at least three years. These form part of a one-off £320m integration cost alluded to in the companies’ merger announcement in March. The merger of Aberdeen and Standard Life will create Europe’s second-largest fund manager, with an estimated £660bn under management.

 

Aberdeen Asset Management’s revenue increased by 10.6% to £534.9m in the six months to the end of March and underlying profit before tax rose by 19.8% to £195.2m. The group’s assets under management totalled £308,1bn – up from £292.8bn a year ago. Improving trend in net new business flows. The group also said that actions to deliver £70m of annualised cost synergies had now been completed. Chief executive Martin Gilbert said: “These figures reflect improving sentiment towards emerging markets combined with our transition to becoming a full-service asset manager offering a broad range of capabilities via multiple distribution channels globally.

 

Elliott Management will meet with BHP Billiton’s Australian shareholders this week as the activist investor pushes for strategic changes at the world’s biggest miner.  According to two sources familiar with the situation, Elliott was seeking feedback from other investors about its proposed overhaul of BHP. Over the past year, Elliott has built up a 4.1% in the miner and last month told BHP it had failed to deliver “optimal” value.

 

AstraZeneca and its global biologics research and development arm, MedImmune, said the US Food and Drug Administration has granted accelerated approval to the bladder cancer treatment Imfinzi (durvalumab). Imfinzi is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, or whose disease has progressed within 12 months of receiving platinum-containing chemotherapy before or after surgery.

 

NMC Health expects healthcare regulatory changes implemented by His Highness Sheik Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Commander of the UAE Armed Forces to positively impact its entire healthcare portfolio. NMC now expects full year EBITDA to be towards the top end of the current guidance range of $335m-$350mn. The Crown Prince’s statements — regarding regulatory changes to Thiqa cardholders in Abu Dhabi — were confirmed by the Health Authority of Abu Dhabi (HAAD) to NMC on 27th April.

 

Bovis, which was subject to two failed buyout bids earlier this year, said it would take a £2.8m hit from the talks and a review conducted in February after the firm warned on profits. Bovis, which said sales so far this year are in line with reduced building expectations, warned on profits at the end of 2016 after it failed to build enough homes, prompting its chief executive to quit. In April, British housebuilder Galliford Try pulled out of a £1.2bn attempt to buy Bovis after the two failed to agree on price, a week after another potential suitor Redrow also pulled out.

 

Just Eat reported a rise in first quarter revenue, benefiting from the continuing transition to ordering takeaways online rather than by phone. Revenue for the quarter ended 31st March rose 46% to £118.9m from £81.5m a year ago, with order growth climbing by 25% on a comparable basis to 39m, the company said. Just Eat reiterated its full year guidance for revenue between £480m and £495m and underlying earnings before interest, taxation, depreciation and amortization between £157m and £163m.

 

Oil prices edged down, as rising output stoked worries that OPEC-led production cuts may not significantly tighten a bloated market. Oil has been weighed down by the market’s impatience with the slow pace of inventory drawdown, even after major oil producers agreed to cut production by 1.8m barrels per day for the first half of 2017.

 

Gold held near three-week lows hit in the previous session on diminishing demand for safe-haven bullion as Asian equities rallied and the U.S. dollar gained versus the yen.

Companies Reporting this week

Day Companies
Today: BP * Aberdeen Asset Management * Shire
Tomorrow: Direct Line Insurance Group * Imperial Brands * J Sainsbury * Centamin * Sage Group * Indivior
Thursday: HSBC Holdings * Randgold Resources * Lancashire Holdings * Next * Royal Dutch Shell * Inmarsat
Friday: International Consolidated Airlines Group * Smurfit Kappa Group * Millennium & Copthorne Hotels

Early Market Movements

Market Index Change % Change
UK 100 7,249.1 +45.1 +0.6%
UK 250 19,667.3 +51.9 +0.3%
GER 30 12,449.9 +11.9 +0.1%
FRA 40 5,277.4 +10.1 +0.2%
U.S. 30 20,913.46 -27.05 -0.0%
U.S. 500 2,388.3 +4.1 +0.2%
OIL (BRENT) 51.58 +0.06 +0.1%
GOLD 1,256.33 -0.25 -0.0%

UK Risers & Fallers (8:15am)

Company Price Change % Change
Ocado 269.65 +18.65 +7.4%
BP 453.5 +11 +2.5%
Rentokill International 254.9 +5.9 +2.4%
Just Eat 563.5 -13.5 -2.3%
Fresnillo 1422 -30 -2.1%
Rangold Resources 6665 -140 -2.1%

Latest Broker Views

Company Broker Recommendation Price Target
Nostrum Oil & Gas Peel Hunt Buy 448.40 700.00
Standard Chartered HSBC Reduce 710.00 640.00
Anglo American JP Morgan Cazenove Overweight 1,191.75 1,600.00
WPP Group Barclays Capital Overweight 1,675.50 2,050.00

Forthcoming Economic Data

Time/Date Previous Forecast Outcome
9:00am: European Final Manufacturing PMI 56.8 56.8
9:30am: U.K. Manufacturing PMI 54.2 54.0
10:00am: European Unemployment Rate 9.5% 9.4%

Sources:

http://www.marketwatch.com/story/just-eat-revenue-rises-46-in-first-quarter-2017-05-02

http://uk.reuters.com/article/us-bp-results-idUKKBN17Y0GS

http://www.dailymail.co.uk/wires/reuters/article-4464884/UK-builder-Bovis-takes-2-8-mln-pound-hit-failed-merger-talks.html

http://www.stockmarketwire.com/article/5540753/NMC-Health-upbeat-on-FY-EBITDA.html

http://www.stockmarketwire.com/article/5540756/Aberdeen-underlying-pretax-profits-up-19-point-8pct.html

https://www.digitallook.com/news/news-and-announcements/astrazeneca-gets-fda-approval-for-bladder-cancer-treatment–2648645.html

http://www.bbc.co.uk/news/business-39770289

http://www.marketwatch.com/story/us-stocks-set-to-rise-after-government-shutdown-averted-2017-05-01

http://www.theglobeandmail.com/globe-investor/markets/asian-shares-rally-dollar-climbs-amid-tech-optimism/article34870984/

http://www.reuters.com/article/us-global-oil-idUSKBN17X0X1

http://in.reuters.com/article/global-precious-idINKBN17Y0EN

 

Subscribe to our Award-winning Newsletter

We provide daily market data in the form of our award-winning newsletter, The Morning Call and The Market Close.
You can subscribe to this information at any time to help you make the most of your investment.

Quick Sign-up

Recommendations: Collins Sarri Statham Investments Ltd (CSS) does not in any of its publications take into account any particular recipient's investment objectives, financial situation, and specific needs and demands. Therefore, all CSS publications are, unless otherwise specifically stated, intended for informational and/or marketing purposes only.CSS shall not be responsible for any loss arising from any investment based on a perceived recommendation.

No publication (including recommendations) shall be construed as a representation or warranty that the recipient will profit, nor avoid sustaining losses, from trading in accordance with a trading strategy set forth in a publication.

Risk Warning: Trading in the products and services offered by Collins Sarri Statham Investments Ltd (CSS) may, result in losses as well as profits as the value of investments may go down as well as up. You may not get back the full amount you have invested.

Any reference to past performance should not be viewed as an indication of any future performance.

Investments held in overseas markets are subject to the effects of changes in exchange rates which will impact on the value of the underlying investment.

Investments made in AIM and penny shares carry an increased risk due to the difficulty in creating a market in these shares. There may be a substantial difference in the buy and sell price.

Leveraged products such as Contracts for Difference (CFDs), derivatives, commodities & Foreign Exchange (FX), carry a higher risk to your capital. They can lose their value rapidly and you may lose substantially more than your initial investment.

Speculative trading is not suitable for all investors: The information contained herein is based on materials and sources that we believe to be reliable however we make no representation or warranty, either express or implied, in relation to the accuracy, completeness or reliability of the information contained herein. Please note that the figures shown may, in some instances, be rounded to the nearest penny. Prices can move sharply from those quoted in this document. Current prices can be verified by calling one of our brokers. CSS is under no obligation to update the information contained herein. Neither CSS, nor its affiliates, nor its employees shall have any liability whatsoever for any indirect or consequential loss or damage arising from the use of this document.

Get Started with CSS

Open an Account

Subscribe to our award winning daily newsletter

Voted "Best Market Newsletter" in 2012, 2014, 2015 and 2017 by the City of London Wealth Management Awards

Subscribe to our newsletter (Popup)

By signing up to our free email, you are consenting to receive these promotions. The newsletter is sent up to three times per day during the week and up to once per day over the weekend and is directed at UK residents. The newsletter contains company news, market movements, CSS research and promotions and breaking economic news. Occasionally our newsletter will contain advertisements from trusted partners. However, we will never give, sell or rent your email address to any other companies. If you want to stop receiving our free emails you can unsubscribe at any time by clicking on the link at the bottom of each email. You can read our privacy policy here.

Sending
No, thank you I am already subscribed